🔎 Trials Near Me

Home › Atopic Dermatitis (Eczema) › Florida

Pag-aaral pangklinika para sa Atopic Dermatitis (Eczema) sa Florida

19 pag-aaral para sa Atopic Dermatitis (Eczema) ang naghahanap ng mga kalahok sa mga site sa Florida.

Mga Lungsod sa Florida

Opisyal na teksto ng pag-aaral (English)

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

  • Pediatric Skin Research, Miami
  • AllerVie Clinical Research, Panama City
  • GCP Research , Global Clinical Professionals, St. Petersburg
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07765888

Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

  • True Blue Clinical Research, Tampa
Nagre-recruitObservasyonal na pag-aaral
Edad 12 hanggang 89 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07645820

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

  • Leo Pharma Investigational site, Jacksonville
  • Leo Pharma Investigational site, Miami
  • Leo Pharma Investigational site, Tampa
Nagre-recruitPhase 3
6 Months – 11 Years · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06311682

First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis

  • Florida International Research Center, Miami
  • Encore Medical Research of Weston LLC, Weston
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07527923

Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis

  • Arcutis Site 321, Miami Lakes
Nagre-recruitPhase 3
Edad 6 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07916480

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

  • Direct Helpers Research Center, Hialeah
  • Research Associates of South Florida, LLC, Miami
  • Global Health Research Center, Inc., Miami Lakes
  • at 2 pa
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07783425

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

  • Solutions Through Advanced Research, Jacksonville
Nagre-recruitPhase 3
Edad 2 hanggang 11 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06807281

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

  • Miami Dermatology and Laser Research, Miami
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06564389

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

  • Gsi Clinical Research, Margate
Nagre-recruitPhase 2
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07216027

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

  • Investigational Site, Coral Gables
  • Investigational Site, Jacksonville
  • Investigational Site, Margate
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07003425

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

  • St. Jude Clinical Research- Site Number : 8400049, Doral
  • Ziaderm Research, LLC- Site Number : 8400021, North Miami Beach
Nagre-recruitObservasyonal na pag-aaral
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07290803

A Study Evaluating TRIV-573 in Atopic Dermatitis

  • Triveni Bio Site #11, Boca Raton
  • Triveni Bio Site #7, Miami
  • Triveni Bio Site #3, Miami
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07782333

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

  • Clinical Site 112, Miami
  • Clinical Site 110, Miami
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07453602

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

  • Novartis Investigative Site, Miami
  • Novartis Investigative Site, St. Petersburg
Nagre-recruitPhase 2
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06947993

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

  • Enveda Investigative Site, Fort Lauderdale
  • Enveda Investigative Site, Miami
  • Enveda Investigative Site, Miramar
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07298395

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

  • ABMED Clinical Research Corp., Cape Coral
  • Skin Care Research, Hollywood
  • Quality Care Clinical Research, Miami
  • at 4 pa
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07599813

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

  • Inmagene Site 19, Ocala
  • Inmagene Site 4, Tampa
Nagre-recruitPhase 2
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT07037901

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

  • Enveda Investigative Site, Boca Raton
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07643766

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

  • Galderma Investigational Site 8597, Boca Raton
  • Galderma Investigational Site 7087, Coral Gables
  • Galderma Investigational Site 7063, Cutler Bay
  • at 7 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 12 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT06988605

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.